Christopher David Stephen, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Conversion Disorder | 9 | 2022 | 205 | 2.540 |
Why?
|
Spinocerebellar Ataxias | 6 | 2024 | 88 | 2.130 |
Why?
|
Dystonia | 4 | 2023 | 363 | 2.000 |
Why?
|
Gangliosidoses, GM2 | 3 | 2023 | 17 | 1.870 |
Why?
|
Dystonic Disorders | 3 | 2023 | 329 | 1.870 |
Why?
|
Cerebellar Ataxia | 6 | 2024 | 145 | 1.780 |
Why?
|
Eye Movements | 3 | 2020 | 507 | 1.260 |
Why?
|
Movement Disorders | 4 | 2022 | 445 | 1.110 |
Why?
|
Muscle Weakness | 2 | 2022 | 415 | 1.040 |
Why?
|
Gerstmann-Straussler-Scheinker Disease | 1 | 2024 | 10 | 0.970 |
Why?
|
Prions | 1 | 2024 | 181 | 0.830 |
Why?
|
Ocular Motility Disorders | 2 | 2020 | 135 | 0.800 |
Why?
|
Creutzfeldt-Jakob Syndrome | 1 | 2022 | 89 | 0.800 |
Why?
|
Botulinum Toxins | 1 | 2022 | 191 | 0.750 |
Why?
|
Neurodegenerative Diseases | 3 | 2023 | 1062 | 0.630 |
Why?
|
Nervous System Diseases | 5 | 2021 | 1623 | 0.610 |
Why?
|
Intracranial Hypotension | 1 | 2015 | 41 | 0.520 |
Why?
|
Vision Disorders | 1 | 2021 | 1059 | 0.470 |
Why?
|
Accidental Falls | 1 | 2022 | 1062 | 0.470 |
Why?
|
Sodium Chloride | 1 | 2015 | 625 | 0.450 |
Why?
|
Sensation Disorders | 1 | 2014 | 156 | 0.440 |
Why?
|
Copper | 1 | 2014 | 366 | 0.390 |
Why?
|
Ataxia | 5 | 2023 | 304 | 0.330 |
Why?
|
Psychotic Disorders | 1 | 2023 | 3046 | 0.330 |
Why?
|
REM Sleep Behavior Disorder | 2 | 2021 | 105 | 0.320 |
Why?
|
Parkinsonian Disorders | 2 | 2021 | 275 | 0.300 |
Why?
|
Parkinson Disease | 4 | 2021 | 2776 | 0.260 |
Why?
|
Constipation | 2 | 2021 | 546 | 0.250 |
Why?
|
Emergency Service, Hospital | 2 | 2021 | 7659 | 0.240 |
Why?
|
Dysarthria | 1 | 2023 | 57 | 0.220 |
Why?
|
CADASIL | 1 | 2023 | 84 | 0.210 |
Why?
|
Gait | 3 | 2022 | 793 | 0.200 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2023 | 214 | 0.190 |
Why?
|
Pursuit, Smooth | 1 | 2020 | 41 | 0.190 |
Why?
|
Brain | 3 | 2022 | 26413 | 0.190 |
Why?
|
Algorithms | 1 | 2021 | 13885 | 0.180 |
Why?
|
Transglutaminases | 2 | 2021 | 194 | 0.180 |
Why?
|
Adrenoleukodystrophy | 1 | 2022 | 123 | 0.180 |
Why?
|
Disease Progression | 4 | 2023 | 13280 | 0.180 |
Why?
|
Physical Therapy Modalities | 2 | 2022 | 550 | 0.170 |
Why?
|
Spectrum Analysis | 1 | 2021 | 454 | 0.170 |
Why?
|
Paresis | 1 | 2020 | 179 | 0.170 |
Why?
|
Humans | 40 | 2024 | 744220 | 0.170 |
Why?
|
Atrophy | 1 | 2023 | 1582 | 0.170 |
Why?
|
Restless Legs Syndrome | 1 | 2022 | 228 | 0.170 |
Why?
|
Adult | 19 | 2023 | 214035 | 0.160 |
Why?
|
Genetic Counseling | 1 | 2022 | 600 | 0.160 |
Why?
|
Muscles | 1 | 2023 | 1622 | 0.160 |
Why?
|
Expert Testimony | 1 | 2020 | 356 | 0.150 |
Why?
|
Neurosciences | 1 | 2022 | 348 | 0.150 |
Why?
|
Inpatients | 2 | 2021 | 2518 | 0.150 |
Why?
|
Psychophysiologic Disorders | 1 | 2019 | 228 | 0.150 |
Why?
|
Fatal Outcome | 1 | 2022 | 1849 | 0.150 |
Why?
|
Blindness | 1 | 2021 | 617 | 0.140 |
Why?
|
Female | 23 | 2022 | 380197 | 0.140 |
Why?
|
Cerebellum | 2 | 2021 | 1490 | 0.140 |
Why?
|
Cohort Studies | 6 | 2021 | 40559 | 0.140 |
Why?
|
Olfaction Disorders | 1 | 2018 | 222 | 0.130 |
Why?
|
Unfolded Protein Response | 1 | 2017 | 233 | 0.130 |
Why?
|
Middle Aged | 17 | 2022 | 213367 | 0.130 |
Why?
|
Injections, Spinal | 1 | 2015 | 303 | 0.130 |
Why?
|
Diagnostic Tests, Routine | 1 | 2020 | 783 | 0.120 |
Why?
|
Standard of Care | 1 | 2017 | 564 | 0.120 |
Why?
|
Epilepsies, Partial | 1 | 2017 | 436 | 0.110 |
Why?
|
Perception | 1 | 2020 | 1198 | 0.110 |
Why?
|
Tracheal Diseases | 1 | 2013 | 113 | 0.110 |
Why?
|
Bronchial Diseases | 1 | 2013 | 151 | 0.110 |
Why?
|
Myocardial Ischemia | 1 | 2023 | 2148 | 0.100 |
Why?
|
Aged | 8 | 2024 | 163253 | 0.100 |
Why?
|
tau Proteins | 1 | 2021 | 1868 | 0.100 |
Why?
|
Sjogren's Syndrome | 1 | 2013 | 233 | 0.100 |
Why?
|
Family | 1 | 2022 | 3148 | 0.100 |
Why?
|
Case-Control Studies | 4 | 2021 | 21752 | 0.090 |
Why?
|
Male | 16 | 2022 | 350027 | 0.090 |
Why?
|
Psychiatric Status Rating Scales | 1 | 2020 | 6037 | 0.090 |
Why?
|
Adolescent | 6 | 2021 | 85759 | 0.080 |
Why?
|
Child | 5 | 2023 | 77679 | 0.080 |
Why?
|
Health Care Costs | 1 | 2021 | 3209 | 0.070 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2008 | 374 | 0.070 |
Why?
|
Leukemia, Promyelocytic, Acute | 1 | 2008 | 236 | 0.070 |
Why?
|
Chromosomes, Human, Pair 17 | 1 | 2008 | 438 | 0.070 |
Why?
|
Diagnosis, Differential | 1 | 2022 | 12961 | 0.070 |
Why?
|
Amyloidosis | 1 | 2013 | 795 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 3 | 2023 | 35423 | 0.070 |
Why?
|
Young Adult | 6 | 2022 | 56436 | 0.070 |
Why?
|
Severity of Illness Index | 2 | 2022 | 15538 | 0.070 |
Why?
|
Child, Preschool | 4 | 2021 | 40992 | 0.070 |
Why?
|
Sleep | 1 | 2020 | 4623 | 0.060 |
Why?
|
Outpatients | 2 | 2022 | 1486 | 0.060 |
Why?
|
Coronary Artery Disease | 1 | 2023 | 6489 | 0.060 |
Why?
|
Prognosis | 2 | 2021 | 29050 | 0.050 |
Why?
|
Translocation, Genetic | 1 | 2008 | 1420 | 0.050 |
Why?
|
Cognition | 1 | 2020 | 6765 | 0.050 |
Why?
|
Cross-Sectional Studies | 2 | 2020 | 25043 | 0.050 |
Why?
|
Sandhoff Disease | 1 | 2021 | 13 | 0.050 |
Why?
|
Healthcare Disparities | 1 | 2017 | 3158 | 0.050 |
Why?
|
Tay-Sachs Disease | 1 | 2021 | 17 | 0.050 |
Why?
|
Tremor | 1 | 2022 | 175 | 0.050 |
Why?
|
Supranuclear Palsy, Progressive | 1 | 2021 | 77 | 0.050 |
Why?
|
Retrospective Studies | 5 | 2022 | 77426 | 0.050 |
Why?
|
Middle East | 1 | 2021 | 219 | 0.050 |
Why?
|
Stroke | 1 | 2023 | 9981 | 0.050 |
Why?
|
Comorbidity | 3 | 2020 | 10387 | 0.050 |
Why?
|
United States | 4 | 2021 | 69867 | 0.040 |
Why?
|
Mutation | 2 | 2022 | 29784 | 0.040 |
Why?
|
Risk Assessment | 1 | 2021 | 23337 | 0.040 |
Why?
|
Asia | 1 | 2021 | 610 | 0.040 |
Why?
|
Ankle | 1 | 2022 | 327 | 0.040 |
Why?
|
Uncertainty | 1 | 2023 | 734 | 0.040 |
Why?
|
Psychology, Social | 1 | 2017 | 51 | 0.040 |
Why?
|
Cerebral Infarction | 1 | 2023 | 1010 | 0.040 |
Why?
|
Upper Extremity | 1 | 2022 | 648 | 0.040 |
Why?
|
Neuropsychiatry | 1 | 2017 | 55 | 0.040 |
Why?
|
Antiparkinson Agents | 1 | 2018 | 184 | 0.040 |
Why?
|
Computers | 1 | 2019 | 611 | 0.040 |
Why?
|
Postural Balance | 1 | 2021 | 620 | 0.040 |
Why?
|
Parietal Lobe | 1 | 2021 | 838 | 0.030 |
Why?
|
Anxiety | 2 | 2020 | 4297 | 0.030 |
Why?
|
COS Cells | 1 | 2017 | 1161 | 0.030 |
Why?
|
Thalamus | 1 | 2021 | 1024 | 0.030 |
Why?
|
Europe | 1 | 2021 | 3339 | 0.030 |
Why?
|
Phenotype | 2 | 2022 | 16365 | 0.030 |
Why?
|
Movement | 1 | 2021 | 1471 | 0.030 |
Why?
|
Multiple Sclerosis | 1 | 2008 | 3079 | 0.030 |
Why?
|
Prevalence | 2 | 2022 | 15226 | 0.030 |
Why?
|
Animals, Genetically Modified | 1 | 2017 | 1549 | 0.030 |
Why?
|
Endoplasmic Reticulum | 1 | 2017 | 1144 | 0.020 |
Why?
|
Quality of Life | 2 | 2023 | 12805 | 0.020 |
Why?
|
Debridement | 1 | 2013 | 492 | 0.020 |
Why?
|
Psychometrics | 1 | 2020 | 3002 | 0.020 |
Why?
|
Feasibility Studies | 1 | 2019 | 5076 | 0.020 |
Why?
|
Pilot Projects | 1 | 2022 | 8321 | 0.020 |
Why?
|
Mitoxantrone | 1 | 2008 | 149 | 0.020 |
Why?
|
Drosophila melanogaster | 1 | 2017 | 1708 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2017 | 4201 | 0.020 |
Why?
|
Genetic Testing | 1 | 2021 | 3443 | 0.020 |
Why?
|
DNA Topoisomerases, Type II | 1 | 2008 | 121 | 0.020 |
Why?
|
Bronchoscopy | 1 | 2013 | 862 | 0.020 |
Why?
|
Seizures | 1 | 2020 | 2859 | 0.020 |
Why?
|
Neurosurgical Procedures | 1 | 2017 | 2003 | 0.020 |
Why?
|
Introns | 1 | 2008 | 991 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2021 | 13990 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2021 | 57768 | 0.020 |
Why?
|
Socioeconomic Factors | 1 | 2017 | 7784 | 0.010 |
Why?
|
Sex Factors | 1 | 2017 | 10396 | 0.010 |
Why?
|
Cell Line | 1 | 2017 | 15999 | 0.010 |
Why?
|
Lung Diseases | 1 | 2013 | 1885 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 2021 | 19907 | 0.010 |
Why?
|
Depression | 1 | 2020 | 7767 | 0.010 |
Why?
|
Antigens, Neoplasm | 1 | 2008 | 1987 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 21824 | 0.010 |
Why?
|
Neurons | 1 | 2017 | 9335 | 0.010 |
Why?
|
Models, Genetic | 1 | 2008 | 3494 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2017 | 25618 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2017 | 39045 | 0.010 |
Why?
|
Infant | 1 | 2017 | 35129 | 0.010 |
Why?
|
Prospective Studies | 1 | 2019 | 53280 | 0.010 |
Why?
|
DNA | 1 | 2008 | 7303 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2017 | 63119 | 0.010 |
Why?
|
Risk Factors | 1 | 2018 | 72280 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2008 | 9647 | 0.010 |
Why?
|
Animals | 1 | 2017 | 168788 | 0.000 |
Why?
|